FB Pixel Skip to main content

In a recent posting, I discussed the need to obtain mammograms for women beyond a certain age prior to undergoing a breast reduction. The reason for is to screen for any abnormalities that may need to be explored further prior to the reduction mammoplasty surgery. It was also noted that even with a “negative” mammogram, there is an incidence of occult breast cancer identified in the removed breast tissue of between 0.16% and 0.40%.

A retrospective study just published in the October 2009 issue of the Plastic and Reconstructive Surgery Journal evaluated the incidence of precancerous lesions present in the tissue removed in breast reductions. What they discovered was very interesting and clinically helpful in potentially identifying women who are at increased risks of developing invasive breast cancer. Atypical ductal or lobular hyperplasia (abnormal but not cancerous) was diagnosed in the specimens in 4.4% of the women and a non-invasive state of breast cancer (ductal and lobular carcinoma in-situ) was seen in an additional 1.8%.

Why is this important? Based on the pathological diagnosis, a woman’s risk for developing breast cancer in the future can be quantified and appropriate preemptive actions taken as warranted. Atypical ductal and lobular hyperplasia have a 4 – 5 time increased risk of developing invasive breast cancer whereas ductal and lobular carcinoma in situ have and 8 – 10 fold greater risk than the average woman. Ordinary fibrocystic disease has no elevated risk for the later development of breast cancer.

Those women with an elevated risk of developing breast cancer can then be referred to either an oncologist or breast cancer surgeon for further evaluation and possible treatment. This could include prophylactic mastectomies, radiation or even estrogen receptor modulator therapy such as taking tamoxifen.

Therefore, women who undergo breast reductions may now receive an additional benefit from a procedure that already has overwhelmingly positive satisfaction – reducing their risk of developing invasive breast cancer.

If you would like to obtain additional information on breast reduction, breast reconstruction or any cosmetic surgery procedure that I perform or to schedule a consultation, you can contact my office at 480-451-3000.

Steven H. Turkeltaub, M.D. P.C.
Scottsdale and Phoenix, Arizona

Request an Appointment

A Message Regarding Coronavirus/COVID-19

As always, our highest priority is to ensure YOUR safety and well-being.

With coronavirus/COVID-19 still a health issue, we want you to know that we are continuing to take extreme infection control measures in our office to maximize cleanliness and keep the environment as sanitary and safe as possible. This also means that only patients will be permitted to come into our office and everyone will have their temperature checked.

In an abundance of caution, we are requesting that if you are experiencing a fever, cough, chills, fatigue or any type of respiratory illness, please delay any upcoming appointments at our practice. We can talk with you by phone or email to establish a new date and time for the appointment. You may also want to contact your healthcare provider for further evaluation.

We do offer Virtual Consultations and Telemedicine through doxy.me. This is best used for specific situations including postoperative questions and as a substitute for some postoperative office visits relating to certain procedures. However, if you are planning to proceed with surgery, an in-office evaluation will be required.

We are all in this together and really appreciate your cooperation. If you have any questions, please feel free to contact us by phone or email.